LNC
39
-6
MAS
58
2
KMX
47
4
XRAY
34
11
BXP
47
3
HAL
50
3
ADI
47
-2
ORLY
57
3
WFC
66
-5
CINF
37
6
MMM
28
-2
KR
38
-2
GOOG
55
-4
CAT
55
-2
VFC
65
2
UHS
56
4
PEP
47
3
WHR
64
3
JNJ
42
-2
NOV
52
3
LNC
39
-6
MAS
58
2
KMX
47
4
XRAY
34
11
BXP
47
3
HAL
50
3
ADI
47
-2
ORLY
57
3
WFC
66
-5
CINF
37
6
MMM
28
-2
KR
38
-2
GOOG
55
-4
CAT
55
-2
VFC
65
2
UHS
56
4
PEP
47
3
WHR
64
3
JNJ
42
-2
NOV
52
3
Financhill
Back

Cassava Sciences Quote, Financials, Valuation and Earnings

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade
Sell
32

SAVA
Cassava Sciences

Last Price:
25.17
Seasonality Move:
36.31%

7 Day Trial

ALL ACCESS PASS

$ 7

U.S. Government Report Alert Tuesday

Discover the Secret Loophole

Cassava Sciences Price Quote

$25.17
-0.67 (-2.59%)
(Updated: November 5, 2024 at 9:40 AM ET)

Cassava Sciences Key Stats

Sell
32
Cassava Sciences (SAVA) is a Sell
Day range:
$25.45 - $26.70
52-week range:
$8.79 - $42.20
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
27.41
P/B ratio:
6.56%
Volume:
969.2K
Avg. volume:
1.8M
1-year change:
13.83%
Market cap:
$1.2B
Revenue:
$0
EPS:
$-1.41

How Much Does Cassava Sciences Make?

Data Unavailable

Is Cassava Sciences Growing As A Company?

Data Unavailable

Cassava Sciences Stock Price Performance

  • Did Cassava Sciences Stock Go Up Last Month?
    Cassava Sciences share price went down by -4.58% last month
  • Did SAVA's Share Price Rise Over The Last Year?
    SAVA share price rose by 13.83% over the past 1 year

What Is Cassava Sciences 52-Week High & Low?

Cassava Sciences Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Cassava Sciences?

  • How Much Debt Does Cassava Sciences Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Cassava Sciences Have?
    Cash and short term investments quarterly total is $207.3M
  • What Is Cassava Sciences’s Book Value Per Share?
    Book value per share is 3.94

Is Cassava Sciences Cash Flow Positive?

  • What Is SAVA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$86.2M
  • What Is Cassava Sciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $125.2M
  • What Is Cassava Sciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$92K

Cassava Sciences Return On Invested Capital

Data Unavailable

Cassava Sciences Earnings Date & Stock Price

Cassava Sciences Competitors

  • Who Are Cassava Sciences's Competitors?
    Below is a list of companies who compete with Cassava Sciences or are related in some way:
    • Biomarin Pharmaceutical Inc (BMRN)
    • Bristol-Myers Squibb Co (BMY)
    • EyePoint Pharmaceuticals Inc (EYPT)
    • Eli Lilly and Co (LLY)
    • Seelos Therapeutics Inc (SEEL)

Cassava Sciences Dividend Yield

Cassava Sciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -219.25%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 116.00
Upside from Last Price: 348.92%

Major Shareholders

  • How many SAVA shares are owned by institutional investors?
    20.6M SAVA shares are owned by institutional investors
  • How many SAVA shares are owned by insiders?
    2M SAVA shares are owned by insiders